CCND1 and prostate cancer: Our results found that four miRNAs, which include miR-19b, miR-23b, miR-26a and miR-92a, promote cell proliferation of prostate cancer in vitro by targeting regulation of PTEN and its downstream signals, PI3K/Akt and cyclin D1.